Enhancement of gene delivery using novel homodimeric tat peptide formed by disulfide bond

Journal of Microbiology and Biotechnology

Volumn 21, Issue 8, 2011, Pages 802-807

  Soo Jin, Lee ^a   Yoon, Sung Hwa ^a   Doh, Kyung Oh ^b,c  

^a Ajou University   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

^c Yeungnam University   (South Korea)

Author keywords

Gene therapy; Liposome; Tat peptide; Transfection

Indexed keywords

1,2 DIMYRISTYLOXYPROPYL 3 DIMETHYLHYDROXYETHYLAMMONIUM BROMIDE; 1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CYSTINE; DNA; GREEN FLUORESCENT PROTEIN; HOMODIMER; LIPOFECTAMINE; LIPOSOME; LUCIFERASE; PEPTIDE; TAT CTHD PEPTIDE; TAT NTHD PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASSAY; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIMERIZATION; DISULFIDE BOND; GEL RETARDATION ASSAY; HUMAN; HUMAN CELL; LIPOSOMAL GENE DELIVERY SYSTEM; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROTEIN DNA BINDING; PROTEIN MODIFICATION; PROTEIN STRUCTURE; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE CELL;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; DIMERIZATION; DISULFIDES; HUMANS; LIPOSOMES; MALE; MOLECULAR SEQUENCE DATA; MYOCYTES, SMOOTH MUSCLE; PEPTIDE FRAGMENTS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSFECTION;

HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS;

EID: 80052276442     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1105.05041     Document Type: Article

References (33)

1. Anwer, K., M. N. Barnes, J. Fewell, D. H. Lewis, and R. D. Alvarez. 2010. Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer. Gene Ther. 17: 360-369.
2. Astriab-Fisher, A., D. Sergueev, M. Fisher, B. R. Shaw, and R. L. Juliano. 2002. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: Effects on cellular uptake, binding to target sequences, and biologic actions. Pharm. Res. 19: 744-754.
3. Bulaj, G., T. Kortemme, and D. P. Goldenberg. 1998. Ionizationreactivity relationships for cysteine thiols in polypeptides. Biochemistry 37: 8965-8972.
4. Cheng, S., W. S. Craig, D. Mullen, J. F. Tschopp, D. Dixon, and M. D. Pierschbacher. 1994. Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists. J. Med. Chem. 37: 1-8.
5. Elmquist, A., M. Lindgren, T. Bartfai, and U. Langel. 2001. VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp. Cell Res. 269: 237-244.
6. Frankel, A. D. and C. O. Pabo. 1988. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55: 1189-1193.
7. Green, M. and P. M. Loewenstein. 1988. Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein. Cell 55: 1179-1188.
8. Hu, Y., K. Li, L. Wang, S. Yin, Z. Zhang, and Y. Zhang. 2010. Pegylated immuno-lipopolyplexes: A novel non-viral gene delivery system for liver cancer therapy. J. Control. Release 144: 75-81.
9. Hyndman, L., J. L. Lemoine, L. Huang, D. J. Porteous, A. C. Boyd, and X. Nan. 2004. HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J. Control. Release 99: 435-444.
10. Ignatovich, I. A., E. B. Dizhe, A. V. Pavlotskaya, B. N. Akifiev, S. V. Burov, S. V. Orlov, and A. P. Perevozchikov. 2003. Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. J. Biol. Chem. 278: 42625-42636.
11. Joliot, A., C. Pernelle, H. Deagostini-Bazin, and A. Prochiantz. 1991. Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. USA 88: 1864-1868.
12. Karmali, P. P. and A. Chaudhuri. 2007. Cationic liposomes as non-viral carriers of gene medicines: Resolved issues, open questions, and future promises. Med. Res. Rev. 27: 696-722.
13. Kawase, Y., D. Ladage, and R. J. Hajjar. 2011. Rescuing the failing heart by targeted gene transfer. J. Am. Coll. Cardiol. 57: 1169-1180.
14. Lanford, R. E., P. Kanda, and R. C. Kennedy. 1986. Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell 46: 575-582.
15. Lo, S. L. and S. Wang. 2008. An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials 29: 2408-2414.
16. Maeda, H., J. Wu, T. Sawa, Y. Matsumura, and K. Hori. 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J. Control. Release 65: 271-284.
17. McKenzie, D. L., K. Y. Kwok, and K. G. Rice. 2000. A potent new class of reductively activated peptide gene delivery agents. J. Biol. Chem. 275: 9970-9977.
18. McKenzie, D. L., E. Smiley, K. Y. Kwok, and K. G. Rice. 2000. Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. Bioconjug. Chem. 11: 901-909.
19. Moon, I. J., H. Kang, Y. B. Seu, B. C. Chang, D. K. Song, and J. G. Park. 2007. Marked transfection enhancement by the DPL (DNA/peptide/lipid) complex. Int. J. Mol. Med. 20: 429-437.
20. Oh, Y. K. and T. G. Park. 2009. siRNA delivery systems for cancer treatment. Adv. Drug Deliv. Rev. 61: 850-862.
21. Pappalardo, J. S., V. Quattrocchi, C. Langellotti, S. Di Giacomo, V. Gnazzo, V. Olivera, et al. 2009. Improved transfection of spleen-derived antigen-presenting cells in culture using TATpliposomes. J. Control. Release 134: 41-46.
22. Park, Y., K. Y. Kwok, C. Boukarim, and K. G. Rice. 2002. Synthesis of sulfhydryl cross-linking poly(ethylene glycol)-peptides and glycopeptides as carriers for gene delivery. Bioconjug. Chem. 13: 232-239.
23. Piron, J., K. L. Quang, F. Briec, J. C. Amirault, A. L. Leoni, L. Desigaux, et al. 2008. Biological pacemaker engineered by nonviral gene transfer in a mouse model of complete atrioventricular block. Mol. Ther. 16: 1937-1943.
24. Pooga, M., M. Hallbrink, M. Zorko, and U. Langel. 1998. Cell penetration by transportan. FASEB J. 12: 67-77.
25. Qin, B. and K. Cheng. 2011. Silencing of the IKKepsilon gene by siRNA inhibits invasiveness and growth of breast cancer cells. Breast Cancer Res. 12: R74.
26. Rudolph, C., C. Plank, J. Lausier, U. Schillinger, R. H. Muller, and J. Rosenecker. 2003. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J. Biol. Chem. 278: 11411-11418.
27. Siprashvili, Z., F. A. Scholl, S. F. Oliver, A. Adams, C. H. Contag, P. A. Wender, and P. A. Khavari. 2003. Gene transfer via reversible plasmid condensation with cysteine-flanked, internally spaced arginine-rich peptides. Hum. Gene Ther. 14: 1225-1233.
28. Torchilin, V. P., T. S. Levchenko, R. Rammohan, N. Volodina, B. Papahadjopoulos-Sternberg, and G. G. D'Souza. 2003. Cell transfection in vitro and in vivo with nontoxic TAT peptideliposome- DNA complexes. Proc. Natl. Acad. Sci. USA 100: 1972-1977.
29. Vijayanathan, V., T. Thomas, and T. J. Thomas. 2002. DNA nanoparticles and development of DNA delivery vehicles for gene therapy. Biochemistry 41: 14085-14094.
30. Vives, E., P. Brodin, and B. Lebleu. 1997. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272: 16010-16017.
31. Wadia, J. S., R. V. Stan, and S. F. Dowdy. 2004. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10: 310-315.
32. Yamano, S., J. Dai, C. Yuvienco, S. Khapli, A. M. Moursi, and J. K. Montclare. 2011. Modified Tat peptide with cationic lipids enhances gene transfection efficiency via temperature-dependent and caveolae-mediated endocytosis. J. Control. Release. [In Press.]
33. Zhang, S., B. Zhao, H. Jiang, B. Wang, and B. Ma. 2007. Cationic lipids and polymers mediated vectors for delivery of siRNA. J. Control. Release 123: 1-10.